Use of Extrusion - Enabled Pharmaceutical Processes in Drug Development
via
a Streamlined Regulatory Pathway
Free Seminar
| Date: | Thursday, August 27, 2015 |
| Time: | 9:00 a.m. - 12:00 p.m. |
| Location: | North Carolina Biotechnology Center Congress Room 15 TW Alexander Drive Research Triangle Park, NC |
Join us for a free half-day educational seminar on combining extrusion-enabled pharmaceutical development with a streamlined regulatory strategy based on the 505(b)(2) NDA pathway to achieve superior product quality attributes and facilitate the drug development and registration process flow. You will learn
- The elements of drug development strategies incorporating extrusion-enabled processes and streamlined regulatory strategies
- How extrusion-based pharmaceutical development helps enable continuous product manufacturing that is more efficient than traditional batch manufacturing
- How to enhance bioavailability of poorly soluble APIs, generate new intellectual property and gain productivity by switching to continuous wet granulation processes
- How the 505(b)(2) regulatory pathway facilitates time and cost efficiency of drug development without compromising patient safety
- Illustrative examples of extrusion enabled processes and streamlined regulatory requirements in approved products
Seating is limited, so register today using the form on the right to reserve your space!
